Grey spots in a patient with dystrophic epidermolysis bullosa.
Schwieger-Briel
A
A
Kiritsi
D
D
Schumann
H
H
Meiss
F
F
Technau
K
K
Bruckner-Tuderman
L
L
D000328:Adult; D000891:Anti-Infective Agents, Local / Q000009:adverse effects*; D001129:Argyria / Q000209:etiology / Q000473:pathology; D016108:Epidermolysis Bullosa Dystrophica / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006801:Humans; D012837:Silver Sulfadiazine / Q000009:adverse effects*
D000891:Anti-Infective Agents, Local; D012837:Silver Sulfadiazine